Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

SanoGene Theraputics

SanoGene Theraputics
Out of Business LATEST DEAL TYPE

Developer of biopharmaceutical products designed to prevent deadly cancers. The company's biopharmaceutical products utilize innovative RNAi-based technologies that combines the capabilities of multiple therapeutics into one deliverable product with synergistic effects, enabling patients to avail next generation of cancer treatment.

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Chicago, IL
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore SanoGene Theraputics’s full profile, request a free trial.

SanoGene Theraputics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 00000 Completed Out of Business
2. Seed Round 26-May-2009 00000 00000 Completed Startup
1. Grant 01-Nov-2006 $86K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »